MedTrace Logo

Bariatric Surgery and Fatty Liver Disease

NCT04569396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2020-10-05

No results posted yet for this study

Summary

The study is based on data from morbidly obese patients who fulfilled the criteria for bariatric surgery during 2016-2018 at the Department of Surgery, University Hospital Ostrava, Czech Republic.

Conditions

Interventions

DIAGNOSTIC_TEST

Biochemistry analysis

Biochemistry analysis of liver parameters were analyzed among the study subjects before and after the surgery.

DIAGNOSTIC_TEST

NAFLD fibrosis score

NAFLD fibrosis score was determined among the study subjects before and after the surgery.

OTHER

BMI measurement

BMI was measured among the study subjects before and after the surgery.

DIAGNOSTIC_TEST

Fibrosis 4 Index

Fibrosis 4 Index was determined among the study subjects before and after the surgery.

DIAGNOSTIC_TEST

Fatty Liver Index

Fatty Liver Index was determined among the study subjects before and after the surgery.

Sponsors & Collaborators

  • University of Ostrava

    collaborator OTHER

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Daniel Toman, MD · University Hospital Ostrava

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-12
Primary Completion
2018-12-16
Completion
2019-12-16

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04569396 on ClinicalTrials.gov